ArticleCureus2024
A Case Report of Early Onset Intrahepatic Cholestasis of Pregnancy.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder occurring in pregnancy presenting with pruritus and the presence of increased levels of serum bile acid. Early onset ICP occurs when this presents before 24 weeks of gestation. This is a rare presentation but can pose a great clinical dilemma. Most often, there are no considerable maternal problems from ICP other than pruritus, which sometimes significantly impacts the quality of life. However, there can be adverse foetal outcomes and complications such as stillbirth. We present the case of an early onset presentation of ICP in a 27-year-old primigravid woman with pruritus and rapidly rising serum bile acid concentration. This report highlights the clinical course and presentation, diagnostic workup, and management approach. In the second trimester, the patient's bile acid levels rose rapidly from 15 μmol/L to 273 μmol/L (normal range: 0-18 μmol/L) over a short time. Her alanine aminotransferase also increased from 22 U/L to 141 U/L (normal range: 0-55 U/L). This prompted close feto-maternal monitoring and swift, robust intervention. She later on went into preterm labour at 30 weeks' gestation and delivered via category 1 lower segment caesarean section due to foetal distress in labour. We highlight through this case that early recognition, close monitoring, and multi-disciplinary care are key to optimise maternal and foetal outcomes in early onset ICP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.